Niels Møller, Evaxion CEO, gets awarded Best CEO in the Vaccination Industry 2016. As we are closer than ever before to understanding the human body on a genetic level, billions of genetic sequences can be processed every day, transforming a biological challenge into a big data one. Led by CEO and co-founder Niels Møller, Evaxion Biotech is tackling that big data challenge to develop meaningful healthcare interventions.
Pioneering the use of bioinformatics, Evaxion has constructed platforms capable of predicting, ranking and optimizing antigens and epitopes that elicit a protective immune response against infectious diseases and cancers. Evaxion is leveraging these platforms to build a solid pipeline of vaccines against diseases with a high medical need.